Recap: Spero Therapeutics Q3 Earnings

Spero Therapeutics SPRO reported its Q3 earnings results on Monday, November 13, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Spero Therapeutics missed estimated earnings by 100.0%, reporting an EPS of $-0.06 versus an estimate of $-0.03.

Revenue was up $23.47 million from the same period last year.

Last quarter the company beat on EPS by $0.11 which was followed by a 3.45% drop in the share price the next day.

Here's a look at Spero Therapeutics's past performance:

Quarter	Q2 2023	Q1 2023	Q4 2022	Q3 2022
EPS Estimate	-0.34	-0.33	0.04	-0.30
EPS Actual	-0.23	-0.25	0.55	-0.33
Revenue Estimate	1.07M	1.00M	22.87M	5.42M
Revenue Actual	2.72M	2.07M	47.44M	2.01M

To track all earnings releases for Spero Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar